Page results
-
It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
-
The children's FGM service is a dedicated monthly multidisciplinary clinic for girls under 18 years old who have had, are suspected to have had, or who may be at risk of having, FGM.
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
A smartphone app that identifies severe neonatal jaundice could provide a cheaper alternative to expensive screening procedures, according to a study by UCLH, UCL and the University of Ghana.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
A combination of two drugs could be an effective treatment for the debilitating disease lupus, according to preliminary evidence from a UCLH led trial.
-
NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.
-
This page provides information about food and drink which may affect your ileostomy output.
File results
-
FOI/2024/0148 - Cleaning audit system at Trust
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer
-
FOI/2024/0162 - Various technology systems/ services used at Trust
-
FOI/2024/0163 - Renal cell carcinoma and melanoma treatments
-
FOI/2024/0166 - Recruitment systems/CRM platform
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0172 - Patients excluded from care at the Trust 2010-2023
-
FOI/2024/0179 - Water usage/ procurement
-
FOI/2024/0183 - Immunology Hidradenitis Suppurativa (HS) treatment